Maximilian Merz: How to Train Your Virtual Twin with 10 Million Euros
Maximilian Merz, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in The Lancet Haematology:
“How to Train Your Virtual Twin.
We’re proud to share our feature in The Lancet Haematology of The Lancet Group – highlighting the CERTAINTY project: a €10 million (about $12M) EU-funded consortium building virtual twins to personalize CAR T-cell therapy for multiple myeloma.
Imagine: your digital doppelgänger trained on your health data, predicting outcomes, side effects and the best treatment strategy – before anything touches the patient.
This is personalized medicine 2.0 – a true pan-European collaboration across science, medicine and AI.
Grateful to work with amazing partners from 🇩🇪🇳🇱🇨🇿🇱🇺 and beyond!
Thanks to the coauthors and the brains behind the operation.”
Title: Virtual twins for personalised CAR T-cell therapy in myeloma
Authors: Kristin Reiche, Ulrike Weirauch, Markus Kreuz, Luise Fischer, Luuk Gras, Thomas Neumuth, Uwe Platzbecker, Ulrike Köhl, Regina Demlova, Andreas Kremer, Holger Fröhlich, Stefan Franke, Maximilian Merz
You can read the Full Article in The Lancet Haematology.
More posts featuring Maximilian Merz.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023